Tag:
Bexsero
Latest Headlines
Latest Headlines
Novartis vaccine Bexsero combats meningitis
Novartis ( $NVS ) is reporting its vaccine Bexsero stimulated an immune response against three strains of the meningococcus B bacterium. An approval would open the door to jabs that would combat the
Novartis' Bexsero successfully protects vast majority of infants
A vaccine against meningococcal B disease, a devastating bacterial infection that is hard to diagnose and can kill in 24 hours, has come a step closer with infant Phase IIb data for Novartis' ( $NVS )
Novartis vax against MenB shows benefits in infant study
Novartis appears to have made more progress in the battle against meningitis B. The Swiss drug giant says that its experimental vaccine Bexsero (a.k.a. 4CMenB) could protect against about 80 percent
